Faculty Retreat Assesses Research Opportunities for The Mount Sinai IPM Biobank

Mount Sinai Leadership and Faculty identified new research and grant opportunities that can now be supported by the IPM Biobank resource.

New York, NY
 – July 1, 2010 /Press Release/  –– 

Mount Sinai Medical Center Leadership and Faculty participated in a retreat organized by the Charles R. Bronfman Institute for Personalized Medicine (IPM) and Conduits-Institutes for Translational Sciences on June 30th, 2010. Leaders of Mount Sinai’s departments, institutes, centers and major research programs discussed the opportunities for new research and grant activities that can now be supported by the IPM Biobank resource. Dean Charney presented his vision of IPM Biobank resource within the context of Mount Sinai at large. Drs. Sampson and Desnick spoke about the role of IPM Biobank for CTSA and the Genome Institute respectively. Dr. Bottinger gave an overview of Biobank’s vision, operations, utilization and projections. Eight disease-specific taskforce reports were presented: Metabolic Disorders/Aging; Cancer/Hematology; Cardiovascular/Hypertension/Renal; Neuropsychiatric; Gastrointestinal/Liver/Pulmonary; Autoimmune Disorders/Infectious Diseases/Emerging Pathogens; Child Health/Allergy/Mendelian Disorders/Development; Pharmacogenetics/Experimental Therapeutics. 

Full videocast of all the presentations made at the Biobank retreat are available at http://www.biobank-mountsinai.org.